Zebrafish disease models in drug discovery: from preclinical modelling to clinical trials

• Published in: Nature reviews. Drug discovery Vol. 20; no. 8; pp. 611 - 628
• Main Authors: Patton, E. Elizabeth, Zon, Leonard I., Langenau, David M.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 01-08-2021; Nature Publishing Group
• Subjects: 631/154/1435; 631/208; 631/67/70; 631/92/613; Animal models in research; Animals; Biomedical and Life Sciences; Biomedicine; Biotechnology; Cancer; Cancer Research; Clinical trials; Clinical Trials as Topic - statistics & numerical data; Design; Developmental biology; Disease; Disease Models, Animal; Drug Discovery; Drug Evaluation, Preclinical - methods; Drugs; Embryos; Etiology; Genome editing; High-Throughput Screening Assays; Humans; Medicinal Chemistry; Methods; Molecular Medicine; Pharmacology, Experimental; Pharmacology/Toxicology; Physiology; Review Article; Zebra fish; Zebrafish; United Kingdom
• ISSN: 1474-1776; 1474-1784
• DOI: 10.1038/s41573-021-00210-8

Numerous drug treatments that have recently entered the clinic or clinical trials have their genesis in zebrafish. Zebrafish are well established for their contribution to developmental biology and have now emerged as a powerful preclinical model for human disease, as their disease characteristics, aetiology and progression, and molecular mechanisms are clinically relevant and highly conserved. Zebrafish respond to small molecules and drug treatments at physiologically relevant dose ranges and, when combined with cell-specific or tissue-specific reporters and gene editing technologies, drug activity can be studied at single-cell resolution within the complexity of a whole animal, across tissues and over an extended timescale. These features enable high-throughput and high-content phenotypic drug screening, repurposing of available drugs for personalized and compassionate use, and even the development of new drug classes. Often, drugs and drug leads explored in zebrafish have an inter-organ mechanism of action and would otherwise not be identified through targeted screening approaches. Here, we discuss how zebrafish is an important model for drug discovery, the process of how these discoveries emerge and future opportunities for maximizing zebrafish potential in medical discoveries.
Zebrafish are useful model organisms for drug discovery, particularly in screening, disease modelling and toxicity assays. Here, Patton, Zon and Langenau discuss key recent successes in which zebrafish models have had key roles. Advances in gene modification technologies have enabled individual mutations to be recapitulated in zebrafish, leading to individualized treatments. Zebrafish xenografts as cancer models could also lead to rapid, personalized platforms for drug discovery.